These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10234287)

  • 1. [Combination chemotherapy--present status and problems].
    Furue H
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):589-96. PubMed ID: 10234287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The chemotherapy for hepatocellular carcinoma].
    Nagano H; Sakon M; Monden M
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1895-900. PubMed ID: 14650956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of combination chemotherapy].
    Ogawa M
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):171-9. PubMed ID: 2418788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
    Yoh K; Goto K; Ishii G; Niho S; Ohmatsu H; Kubota K; Kakinuma R; Nagai K; Suga M; Nishiwaki Y
    Cancer; 2003 Sep; 98(5):926-31. PubMed ID: 12942558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic arterial infusion chemotherapy using totally implantable port system].
    Takayasu Y; Yamamoto S; Ikeda J
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treating Hodgkin's disease: for whom the more means better?].
    Illés A
    Magy Onkol; 2004; 48(2):157-61. PubMed ID: 15351812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].
    Tichler T; Ghodsizade E; Katz A; Rath P; Berger R; Brenner H
    Harefuah; 1999 Nov; 137(9):387-90, 430. PubMed ID: 11419042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
    Bonadonna G; Zambetti M; Moliterni A; Gianni L; Valagussa P
    J Clin Oncol; 2004 May; 22(9):1614-20. PubMed ID: 15117983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma.
    Lee CK; Barlogie B; Munshi N; Zangari M; Fassas A; Jacobson J; van Rhee F; Cottler-Fox M; Muwalla F; Tricot G
    J Clin Oncol; 2003 Jul; 21(14):2732-9. PubMed ID: 12860952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
    Mishima Y; Nagasaki E; Terui Y; Irie T; Takahashi S; Ito Y; Oguchi M; Kawabata K; Kamata S; Hatake K
    Cancer; 2004 Sep; 101(6):1437-44. PubMed ID: 15368332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical effect of hyperthermia combined with induced hypertension chemotherapy].
    Hayashida S; Sugimoto K; Kobayashi T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1218-24. PubMed ID: 6203489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].
    Kamoshita N; Yokomori T; Iesato H; Ohya T; Nagaoka H; Okabe T; Kato Y; Takeyoshi I; Ohwada S; Morishita Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):711-6. PubMed ID: 10832439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of solid tumors in private practice in Malaysia.
    Narasimha K
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1220-3. PubMed ID: 1514835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.